How are Researchers Addressing Resistance to ABL Kinase Inhibitors?
Researchers are exploring various strategies to address resistance to ABL kinase inhibitors. These include the development of new inhibitors that can target multiple mutations, combination therapies that use TKIs with other therapeutic agents, and identifying biomarkers that can predict resistance. Additionally, ongoing research aims to understand the molecular mechanisms underlying resistance to design more effective treatments.
